Cargando…
PIM Kinase as an Executional Target in Cancer
PIM (proviral integration site for moloney murine leukemia virus) kinase plays a key role as an oncogene in various cancers including myeloma, leukemia, prostate and breast cancers. The aberrant expression and/or activation of PIM kinases in various cancers follow an isoform-specific pattern. While...
Autores principales: | Zhang, Xinning, Song, Mengqiu, Kundu, Joydeb Kumar, Lee, Mee-Hyun, Liu, Zhen-Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197848/ https://www.ncbi.nlm.nih.gov/pubmed/30370255 http://dx.doi.org/10.15430/JCP.2018.23.3.109 |
Ejemplares similares
-
Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015) -
An overview of pim kinase as a target in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
por: Clements, Amber N., et al.
Publicado: (2022) -
Targeting Pim kinases in hematological cancers: molecular and clinical review
por: Bellon, Marcia, et al.
Publicado: (2023) -
(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity
por: Song, Mengqiu, et al.
Publicado: (2019)